COVID-19 Pandemic and the New State of Oncology Practice: An Editorial

Hani Ashamalla¹, Mark Ashamalla¹ and Samy I. McFarlane^2,

¹Radiation Oncology Department, New York Presbyterian- Brooklyn Methodist hospital, Brooklyn, NY USA

²Department of Medicine, Downstate -Health Science University, Brooklyn, NY USA

Cite this paper:
Hani Ashamalla, Mark Ashamalla and Samy I. McFarlane. COVID-19 Pandemic and the New State of Oncology Practice: An Editorial. American Journal of Medical Case Reports. 2020; 8(9):311-312. doi: 10.12691/ajmcr-8-9-13

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Liang W, Guan W, Chen R, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020; 21(3): 335‐337.
[2]	J. Ferlay, M. Ervik, F. Lam, et al. Global Cancer Observatory: Cancer Today International Agency for Research on Cancer, Lyon, France (2018). https://gco.iarc.fr/today, Accessed 5th Apr 2020
[3]	Yang F, Shi S, Zhu J, Shi J, Dai K, Chen X. Clinical characteristics and outcomes of cancer patients with COVID-19 [published online ahead of print, 2020 May 5]. J Med Virol. 2020; 10.1002/jmv.25972.
[4]	Schreiber RD, Old LJ, Smyth MJ. Cancer immunoediting: integrating immunity’s roles in cancer suppression and promotion. Science 2011; 331: 1565-70.
[5]	Cai G. Bulk and single-cell transcriptomics identify tobacco-use disparity in lung gene expression of ACE2, the receptor of 2019-nCov. medRxiv 2020.
[6]	Xia Y, Jin R, Zhao J, Li W, Shen H. Risk of COVID-19 for patients with cancer. Lancet Oncol. 2020; 21(4):e180.
[7]	Kattan J, Kattan C, Assi T. Do checkpoint inhibitors compromise the cancer patients' immunity and increase the vulnerability to COVID-19 infection?. Immunotherapy. 2020; 12(6): 351-354.
[8]	Nagar, H., Formenti, S.C. Cancer and COVID-19 — potentially deleterious effects of delaying radiotherapy. Nat Rev Clin Oncol (2020).
[9]	Kutikov A, Weinberg DS, Edelman MJ, Horwitz EM, Uzzo RG, Fisher RI. A War on Two Fronts: Cancer Care in the Time of COVID-19 [published online ahead of print, 2020 Mar 27]. Ann Intern Med. 2020; M20-1133.
[10]	Shimabukuro-Vornhagen A, Gödel P, Subklewe M, et al. Cytokine release syndrome. J Immunother Cancer. 2018; 6(1): 56. Published 2018 Jun 15.